www.achaten-suisse.com
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- HIV
- Alzheimer's And Parkinson's
- Erectile Dysfunction
- Surgery
- Cardiovascular Diseases
- Eye Care
- Urinary Tract
- Antiallergic
- Skin Care
- Obesity
- Respiratory Tract
- Cancer
- Analgesics
- Mental Disorders
- Alcoholism
- Gastrointestinal Tract
- Diabetes
- Men's Health
- Antiparasitic
- Arthritis
- Osteoporosis
- Anticonvulsants
- Cholesterol
- Hypertension
- Antifungals
- Stop Smoking
- Birth Control
- Women's Health
- Antibiotics
- Migraine
- Diuretics
- Antidepressants
- Asthma
- Neurological Disorders
- Anti-inflammatories
- Antivirals
- Muscle Relaxants
| Package | Price | Per pill | Savings | Order |
|---|---|---|---|---|
| 13.9% 15g × 1 tube | £44.67 | £44.67 | Add to cart | |
| 13.9% 15g × 2 tube | £80.43 | £40.22 | £8.91 | Add to cart |
| 13.9% 15g × 3 tube | £108.53 | £36.18 | £25.48 | Add to cart |
Most popular quantity.
Products from the same category
Choose Your language:
- Testimonials
-
I have rec'd the order, and was pleased with every aspect of the order. I do look forward to ordering in the future, so could you please keep in contact with me via this email.
Read more »
-
- Cipher Pharmaceuticals Inc (CPH) Downgraded by Bloom Burton to “Hold” - BNB Daily (blog)
- Cipher Pharmaceuticals Inc (CPH) Downgraded by Bloom Burton to “Hold”BNB Daily (blog)Cipher Pharmaceuticals Inc logo Bloom Burton lowered shares of Cipher Pharmaceuticals Inc (TSE:CPH) (NASDAQ:CPHR) from a buy rating to a hold rating in a research note released on Monday morning
- Cipher Pharmaceuticals Inc (CPH) Given New C$6.50 Price Target at TD Securities - BNB Daily (blog)
- Cipher Pharmaceuticals Inc (CPH) Given New C$6
- Cipher Pharmaceuticals (CPHR) Getting Somewhat Positive Press Coverage, Report Finds - Sports Perspectives
- Cipher Pharmaceuticals (CPHR) Getting Somewhat Positive Press Coverage, Report FindsSports PerspectivesCipher Pharmaceuticals logo Media stories about Cipher Pharmaceuticals (NASDAQ:CPHR) (TSE:CPH) have trended somewhat positive this week, Accern Sentiment Analysis reports
- Cipher Pharmaceuticals (CPHR) Getting Somewhat Favorable Press Coverage, Study Shows - Sports Perspectives
- Cipher Pharmaceuticals (CPHR) Getting Somewhat Favorable Press Coverage, Study ShowsSports PerspectivesCipher Pharmaceuticals logo News stories about Cipher Pharmaceuticals (NASDAQ:CPHR) (TSE:CPH) have been trending somewhat positive on Saturday, according to Accern Sentiment
- John Mull Buys 8500 Shares of Cipher Pharmaceuticals Inc (CPH) Stock - BNB Daily (blog)
- BNB Daily (blog)John Mull Buys 8500 Shares of Cipher Pharmaceuticals Inc (CPH) StockBNB Daily (blog)Cipher Pharmaceuticals logo Cipher Pharmaceuticals Inc (TSE:CPH) (NASDAQ:CPHR) insider John Mull acquired 8,500 shares of the firm's stock in a transaction dated Wednesday, June 28th
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
